Dean, Duke University School of Medicine, United States of America

• Speaker, Keynote Lecture, 21 Sep 2018
 

Prof Mary E. Klotman, MD, was Chair of the Department of Medicine at Duke University March 1, 2010 through July 1, 2017, when she became Dean of the Duke School of Medicine and Vice Chancellor for Health. She earned her undergraduate and medical degrees from Duke, and completed her Internal Medicine residency and fellowship in Infectious Diseases at Duke. She became Assistant Professor of Medicine at Duke, then moved to National Institute of Health in the Laboratory of Tumor Cell Biology. In 1994, Prof Klotman joined the faculty at the Mount Sinai School of Medicine in New York City, where she was a tenured professor of medicine and microbiology and an Associate Professor of gene and cell medicine. She also served as Chief of the Division of Infectious Diseases and Co-director of Mount Global Health and Emerging Pathogens Institute. An accomplished clinician and scientist, Prof Klotman’s research interests are focused on the molecular pathogenesis of Human Immunodeficiency Virus 1 (HIV-1) infection. Prof Klotman and her team demonstrated that HIV resides in and evolves separately in kidney cells, a critical step in HIV-associated kidney disease. Her research group had also determined the role of soluble host factors involved in an innate immune response to HIV in an effort to improve prevention strategies, topical microbicides that could be used to block sexual transmission of HIV. Most recently, her group has been defining the role of integrase-defective lentiviral vectors for the delivery of an HIV vaccine.